Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Rho kinase inhibitors: Filling a gap in glaucoma treatment: Options include mechanism of action on trabecular meshwork without side effects.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Charters, Lynda
- Source:
Ophthalmology Times. Feb2020, Vol. 45 Issue 2, p24-26. 2p.
- Additional Information
- Subject Terms:
- Abstract:
The article offers information on two anti-glaucoma drugs developed by Aerie Pharmaceuticals. These include a netarsudil ophthalmic solution, which is a rho kinase inhibitor, and a netarsudil and latanoprost ophthalmic solution, which is a combination of a prostaglandin and a rho kinase inhibitor. Topics covered include the rho kinase inhibitors' unique mechanism of action to treat glaucoma, and an overview of the glaucoma medication market.
No Comments.